Pais / Región
Paises

Provincias / Departamentos
Colombia Colombia
Argentina Argentina
Canada Canada
Chile Chile
Ecuador Ecuador
España España
Guatemala Guatemala
Honduras Honduras
Mexico Mexico
Panama Panama
Paraguay Paraguay
United States United States
Uruguay Uruguay
Categorias / Industrias
Publication: 2021-10-28 00:00:00
Canada CanadaBuys

Landscape review and analysis of of Canada’s pharmaceutical drug data and advice to support the development of a national drug data strategy (1000234416)

Process Number PW-21-00972774

Dates:


Publication date:

2021-10-28 00:00:00

Amendment date:

None

Date closing:

2021/11/16 14:00 Eastern Standard Time (EST)

Details:


Region of delivery:

National Capital Region

End user entity:

Health Canada

Procurement entity:

Health Canada

Region of opportunity:

Canada

Tendering procedure:

Selective

Reference number:

PW-21-00972774

Solicitation number:

1000234416

Description:


Description:

The Canadian Drug Agency Transition Office requires one (1) Senior Level Business Consultant to provide expert analysis with respect to developing a data strategy for the pharmaceutical management system. The analysis will include three distinct phases of work: Phase 1 – Review of the Drug Data Landscape, Phase 2 – Analysis of Barriers, Strengths and Opportunities for improving access to Drug Data and Phase 3 – Advice on getting started and the Canadian Drug Agency’s role. The Business Consultant will be required over a period of approximately 14 weeks.

Contact information:


Contact name:

Phillips, Wesley

Contact email:

wesley.phillips@canada.ca

Contact phone:

613-941-2067

Contact address:

200 Eglantine Ottawa ON K1A 0K9 CA

Contact Fax:

Solicitation Documents:


File Amendment Number Language Date added

Attachments:


File Amendment Number Language Date added
pr1000234416_npp_for_tsps_english.docx Not available Bilingual 2021-10-28
pr1000234416_npp_for_tsps_french.docx Not available Bilingual 2021-10-28